OGN - Financial Reports List - Organon & Co. - IntrinsicAlpha

Organon & Co. OGN

Healthcare - Drug Manufacturers - General - NYSE - US

$ 13.05

-9.69 %

$ 3.37 B

Market Cap

3.92

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-0.38%	-80.04%	0.00%
Annual Report	FY	10-K	2024-12-31	2.24%	-15.54%	11.98%
Quarterly Report	Q3	8-K	2024-09-30	4.15%	518.97%	168003.45%
Quarterly Report	Q2	8-K	2024-06-30	-0.06%	-19.42%	99128.79%
Quarterly Report	Q1	8-K	2024-03-31	5.46%	13.56%	25.08%
Quarterly Report	Q4	8-K	2023-12-31	7.61%	405.56%	37.44%
Annual Report	FY	10-K	2023-12-31	1.44%	11.56%	-10.22%
Quarterly Report	Q3	8-K	2023-09-30	-1.17%	-74.45%	-99.94%
Quarterly Report	Q2	8-K	2023-06-30	1.45%	3.42%	-99.91%
Quarterly Report	Q1	8-K	2023-03-31	-1.85%	-49.14%	-31.89%

1